Microtubule-stabilizing agents: a growing class of important anticancer drugs

被引：127
|
作者：
Altmann, KH [1 ]
机构：
[1] Novartis Pharma AG, Corp Res, CH-4002 Basel, Switzerland
来源：
CURRENT OPINION IN CHEMICAL BIOLOGY | 2001年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1367-5931(00)00225-8
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Microtubule-stabilizing agents continue to play an important role in anticancer drug discovery and development. New agents were again discovered in the past year, including small synthetic molecules. At least three new taxanes and two compounds of the epothilone class of natural products underwent clinical trials in 2000. Unexpected new findings about synergistic effects between different microtubule-stabilizing agents in vitro raise new prospects for combination chemotherapy.
引用
收藏
页码：424 / 431
页数：8
相关论文
共 50 条
  • [21] The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
    Brunden, Kurt R.
    Yao, Yuemang
    Potuzak, Justin S.
    Ferrer, Nuria Ibarz
    Ballatore, Carlo
    James, Michael J.
    Hogan, Anne-Marie L.
    Trojanowski, John Q.
    Smith, Amos B., III
    Lee, Virginia M. -Y.
    PHARMACOLOGICAL RESEARCH, 2011, 63 (04) : 341 - 351
  • [22] Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs
    Brunden, Kurt R.
    Lee, Virginia M-Y.
    Smith, Amos B., III
    Trojanowski, Bjohn Q.
    Ballatore, Carlo
    NEUROBIOLOGY OF DISEASE, 2017, 105 : 328 - 335
  • [23] Role of tumor hypoxia in acquisition of resistance to microtubule-stabilizing drugs
    Das, Viswanath
    Stepankova, Jana
    Hajduch, Marian
    Miller, John H.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2015, 1855 (02): : 172 - 182
  • [24] Gene expression and mitotic exit induced by microtubule-stabilizing drugs
    Chen, JG
    Yang, CPH
    Cammer, M
    Horwitz, SB
    CANCER RESEARCH, 2003, 63 (22) : 7891 - 7899
  • [25] Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents
    Fojo, T.
    Menefee, M.
    ANNALS OF ONCOLOGY, 2007, 18 : V3 - V8
  • [26] Microtubule-stabilizing agents: New drug discovery and cancer therapy
    Zhao, Ying
    Mu, Xin
    Du, Guanhua
    PHARMACOLOGY & THERAPEUTICS, 2016, 162 : 134 - 143
  • [27] Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents (vol 24, pg 327, 2007)
    Altmann, Karl-Heinz
    Gertsch, Juerg
    NATURAL PRODUCT REPORTS, 2012, 29 (12) : 1481 - 1481
  • [28] Fragment-Based QSAR and Molecular Modeling Studies on a Series of Discodermolide Analogs as Microtubule-Stabilizing Anticancer Agents
    Salum, Livia B.
    Dias, Luiz C.
    Andricopulo, Adriano D.
    QSAR & COMBINATORIAL SCIENCE, 2009, 28 (03): : 325 - 337
  • [29] A common pharmacophore for cytotoxic microtubule-stabilizing agents: Interpretation of SAR studies
    Chakravarty, S
    Lin, SN
    Inoue, T
    Horwitz, SB
    Kuduk, SD
    Danishefsky, SJ
    Ojima, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1196 - U1196
  • [30] Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin
    Saez-Calvo, Gonzalo
    Sharma, Ashwani
    de Asis Balaguer, Francisco
    Barasoain, Isabel
    Rodriguez-Salarichs, Javier
    Olieric, Natacha
    Munoz-Hernandez, Hugo
    Alvaro Berbis, Manuel
    Wendeborn, Sebastian
    Angel Penalva, Miguel
    Matesanz, Ruth
    Canales, Angeles
    Prota, Andrea Enrico
    Jimenez-Barbero, Jesus
    Manuel Andreu, Jose
    Lamberth, Clemens
    Steinmetz, Michel Olivier
    Fernando Diaz, Jose
    CELL CHEMICAL BIOLOGY, 2017, 24 (06): : 737 - +
12345